Myths and truths about transdermal patches
With the large amount of information found on the internet, it is often difficult for us to differentiate truth from myth or lie. That is why in this article we collect some claims of transdermal patches and if they are true or false.
How did the pandemic affect the pharmaceutical industry?
With the appearance of this new disease, in 2019/2020, the pharmaceutical industry is strongly affected.
Cleaning validation in patch manufacturing
Cleaning validation is a procedure of establishing evidence that cleaning processes for manufacturing equipment prevent product contamination
Search for alternative methods for animal experimentation
In recent years, laboratories have been investigating new alternatives to eliminate or avoid animal testing of cosmetic and medical products.
Evaluation of the Adhesion of a Transdermal Patch: Pros & Cons of Proposed Methods
The correct adhesion of a transdermal patch to skin throughout the established time of use is key to guarantee the effective administration of the dose declared in the prescribing information.
Challenges in the analytical method transfer of transdermal pharmaceutical products
Although the analytical procedure transfer of transdermal pharmaceutical products follows the same general guidelines as other dosage forms, ..
Transdermal Patch Manufacturing
The production of transdermal patches is a continuous and artisanal process that consists of 3 stages that reflect how delicate and specific is the production of this niche pharmaceutical form. Let´s review it!
5 advantages of transdermal patches over other types of medication delivery system
In this article we share the most important advantages that transdermal patches have over other dosage forms and routes of administration.
Drug-In Adhesive (DIA) patches, a simple design surrounded of demanding challenges
Far away, in 1979, the first transdermal patch to reach the market, produced under an industrial controlled process and backed by clinical studies, was launched in US under the brand name TransderScop®.
Assessment of the requirements for the submission of generic transdermal systems in Latin America
The Latin American surveillance health authorities have made progress year after year with respect to the requirements of product registration in general, seeking the best balance between the safety of its inhabitants, the efficacy of the products and the economic reality of each country.